We live in a time of tremendous possibility for cancer R&D. Checkpoint inhibitors, cell therapies, molecular diagnostics that catch cancer early and can guide effective custom treatment – these fields are brimming with progress. All were considered speculative at best a decade ago. The science has never been more promising. Yet pricing and access to this new world of cancer therapy remains thorny. These issues have to be resolved if society is going to reap the benefits of this work. Come hear from some of the leading scientists, entrepreneurs, and investors about how they are thinking about the future. All ticket proceeds go to the Kilimanjaro Climb to Fight Cancer, a philanthropic campaign to support basic research at Fred Hutch.

NOTE: Last year’s event sold out in advance, and space is limited. Buy your tickets early to save your seat.

Confirmed speakers:

• Gary Gilliland, president and director, Fred Hutch
• Chad Robins, co-founder and CEO, Adaptive Biotechnologies
• Steve Harr, co-founder and CEO, Sana Biotechnology
• Charlotte Hubbert, partner, Gates Foundation Venture Capital
• Peter Thompson, private equity partner, OrbiMed; co-founder, Silverback Therapeutics
• Sam Blackman, founder and chief medical officer, Day One Therapeutics
• Heidi Hagen, co-founder and chief strategy officer, Vineti*
• Bob More, partner, Alta Partners*
• Thong Le, CEO, Accelerator Life Science Partners
• Clayton Knox, chief operating officer, Mavupharma
• Kristin Anderson, postdoctoral fellow, Fred Hutch Phil Greenberg Lab, Society for Immunotherapy of Cancer Presidential Award-winning young investigator*
• Racquel Bracken, vice president, Venrock
• Brad Gray, CEO, NanoString Technologies
• Tom Daniel, venture partner, ARCH Venture Partners
• Kelly O’Brien, vice president of philanthropy, Fred Hutch*
• Mark Litton, president and COO, Alpine Immune Sciences
• Luke Timmerman, founder and editor, Timmerman Report*
• Carla Grandori, co-founder and CEO, SEngine Precision Medicine

Sponsors:

• Veracyte
• Alexandria Real Estate Equities 
• Takeda Pharmaceuticals
• Foundation Medicine
• Madryn Asset Management
• Alexion

*Denotes Kilimanjaro climber